Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:May 2009
End Date:December 2011
Contact:Benjamin J Sprague, MS
Email:spragueb@upmc.edu
Phone:4126246601

Use our guide to learn which trials are right for you!

Adventitial vasa vasorum (VV) as well as intraplaque microvessels are known to be associated
with atherosclerotic plaque vulnerability. Contrast-enhanced ultrasound has been validated
as a technique to measure the density of VV. Previous studies have demonstrated a
relationship between identification of VV and relationship to vascular events such as stroke
and myocardial infarction. No previous study has reported the utilization of
contrast-enhanced ultrasound identification of VV in the carotid bed as a means of
identifying patients at high risk for acute coronary events.

Aims: In this study, the investigators will aim to identify VV and intraplaque microvessels
along with carotid intima media thickness (CIMT), a known marker for acute coronary events.
The investigators will attempt to measure the correlation of VV with acute coronary events
independent of traditional cardiovascular disease (CVD) risk factors and CIMT.

Methods: 90 volunteers (30 low risk patients, 30 patients with established coronary artery
disease (CAD), and 30 patients with recent acute coronary syndrome (ACS)) will be enrolled.
All patients will undergo contrast-enhanced ultrasound imaging of their carotid arteries and
measurement of CIMT while obtaining baseline histories and assessment of traditional risk
factors for coronary artery disease. VV density and CIMT will be measured in all patients.
Statistical differences in VV among the three groups will be assessed and analyses will be
made to attempt to identify if VV in the carotid bed is an independent predictor of acute
coronary events after controlling for CIMT and traditional risk factors.

Study population: The study population will reflect the patient population of UPMC. No
individual will be excluded on the basis of race, gender, or ethnicity.


Inclusion Criteria:

- Individuals referred for elective left heart catheterization in the past three months
or individuals who have undergone recent left heart catheterization for acute
coronary syndrome in the past 3 months

Exclusion Criteria:

- Inability to provided informed consent

- Pregnancy or of lack confirmed urine or serum B-hcg testing in pre-menopausal women
under the age of 50

- Known allergy to Definity (registered trademark)

- Contraindications to Definity including permanent or transient right to left or
bidirectional cardiac shunts, allergy to perflutren, severe pulmonary hypertension

- Known cocaine abuse within the past year

- History of heart transplantation
We found this trial at
1
site
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials